Evidence to help determine proper treatment in youth with obesity and type 2 diabetes. 

Evidence has shown diabetic treatment options to improve beta-cell function and/or insulin sensitivity, but do these effects persist upon treatment withdrawal?

Myocardial flow reserve plays a significant role as a predictor of cardiac death in patients with diabetes.

New research findings on oral semaglutide vs subcutaneous liraglutide.

The role of 25-hydroxyvitamin D in the progression of type 2 diabetes continues to be explored after a recent study observes diabetes incidence in high risk patients receiving vitamin supplementation.

Thirty years of follow-up data show significant reductions in morbidities and mortality in patients with prediabetes who initiate lifestyle modifications.

Data announced at the 79th annual Scientific Sessions of the ADA shows restoration of beta cell function is possible.

The use of continuous glucose monitoring expanding into clinical practice.

The results of the STENO-2 study assessing the benefit of intensified therapy on risk of stroke.

TrialNet research reveals the benefits of Teplizumab in delaying clinical type 1 diabetes in people at high risk.